This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Email citation

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Case Reports

. 2001 Nov 17;117(16):637-8.

doi: 10.1016/s0025-7753(01)72204-x.

[Acute hepatitis induced by valsartan]

[Article in Spanish]

J M Reñé, J Buenestado, E Sesé, J M Miñana

PMID: 11714476
DOI: 10.1016/s0025-7753(01)72204-x

Case Reports

[Acute hepatitis induced by valsartan]

[Article in Spanish]

J M Reñé et al. Med Clin (Barc). 2001.

. 2001 Nov 17;117(16):637-8.

doi: 10.1016/s0025-7753(01)72204-x.

Authors

J M Reñé, J Buenestado, E Sesé, J M Miñana

PMID: 11714476
DOI: 10.1016/s0025-7753(01)72204-x

No abstract available

PubMed Disclaimer

Similar articles

Valsartan-induced hepatotoxicity in a HBs-Ag-Positive patient.
Kiykim A, Altintas E, Sezgin O, Sezer K, Tiftik N, Akbay E, Seyrek E, Konca K. Kiykim A, et al. Am J Gastroenterol. 2003 Feb;98(2):507. doi: 10.1111/j.1572-0241.2003.07248.x. Am J Gastroenterol. 2003. PMID: 12591083 No abstract available.
Angioedema due to valsartan.
Martínez Alonso JC, Domínguez Ortega FJ, Méndez Alcalde J, Fuentes Gonzalo MJ. Martínez Alonso JC, et al. Allergy. 2003 Apr;58(4):367. doi: 10.1034/j.1398-9995.2003.00064_1.x. Allergy. 2003. PMID: 12708991 No abstract available.
[Biliary stenosis, hepatitis A and valsartan: multifactorial hepatotoxicity in a surgical patient].
Gómez NA, Mejillón JL, Zapatier JA, Vargas PE. Gómez NA, et al. Cir Esp. 2006 Mar;79(3):189-91. doi: 10.1016/s0009-739x(06)70849-1. Cir Esp. 2006. PMID: 16545288 Spanish.
Angiotensin II antagonism in clinical practice: experience with valsartan.
McInnes GT. McInnes GT. J Cardiovasc Pharmacol. 1999;33 Suppl 1:S29-32; discussion S41-3. doi: 10.1097/00005344-199900001-00006. J Cardiovasc Pharmacol. 1999. PMID: 10028951 Review.
Aliskiren/valsartan (Valturna) for hypertension.
[No authors listed] [No authors listed] Med Lett Drugs Ther. 2009 Nov 30;51(1326):94-5. Med Lett Drugs Ther. 2009. PMID: 20224524 Review. No abstract available.

See all similar articles

Cited by

Drug-Induced Liver Injury From Sacubitril-Valsartan Versus a Single Dose of Acarbose.
Achuthanandan S, Dhaliwal A, Patti R. Achuthanandan S, et al. Cureus. 2022 Jul 19;14(7):e27005. doi: 10.7759/cureus.27005. eCollection 2022 Jul. Cureus. 2022. PMID: 35989811 Free PMC article.
Long-Term Safety of a Novel Angiotensin Receptor Blocker, Fimasartan, According to the Absence or Presence of Underlying Liver Disease in Korean Hypertensive Patients: A Prospective, 12-Month, Observational Study.
Oh GC, Joo KW, Kim MA, Choi DJ, Kim YJ, Lee HY. Oh GC, et al. Drug Des Devel Ther. 2020 Apr 3;14:1341-1349. doi: 10.2147/DDDT.S233174. eCollection 2020. Drug Des Devel Ther. 2020. PMID: 32308367 Free PMC article. Clinical Trial.
Angiotensin II protects primary rat hepatocytes against bile salt-induced apoptosis.
Karimian G, Buist-Homan M, Mikus B, Henning RH, Faber KN, Moshage H. Karimian G, et al. PLoS One. 2012;7(12):e52647. doi: 10.1371/journal.pone.0052647. Epub 2012 Dec 26. PLoS One. 2012. PMID: 23300732 Free PMC article.

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Ediciones Doyma, S.L.
- Elsevier Science
Medical
- MedlinePlus Health Information